We've set a new record! More than 4000 practitioners participated in the first "Sino-American TCM Specialist Academic Exchange Forum" on June 28th, 2021, presenting a unique opportunity to share knowledge between Chinese medicine scholars around the world. The online integration seamlessly connected the main venue in Jiangyin City, China with live streaming to participants in Hong Kong, the United States, and Canada. Tianjiang Pharmaceutical, supplier to Treasure of the East, sponsored this exciting event.
CEO of Tianjiang Pharmaceutical, Hu Qifei, welcomed the participants and expressed his gratitude to TCM physicians in the United States and Hong Kong for their long-term support. Mr. Hu pointed out that technological innovation is an important engine for the advancement of Traditional Chinese Medicine.
In the past 30 years, Tianjiang Pharmaceutical has been committed to promoting technological innovation and has achieved fruitful results. Tianjiang Pharmaceutical and the Chinese Society of Traditional Chinese Medicine jointly established a cooperative development platform for disseminating experience in medical specialties, including fertility, chronic pain, thyroid conditions, and health management following cancer treatment.
The forum was Organized by National Federation of Chinese TCM Organizations (NFCTCMO) and Co-Hosted by:
- 全美中醫學會交流群 (ATCMA)
- American Association of Chinese Medicine and Acupuncture (AACMA)
- United Alliance of New York State Licensed Acupuncturists (UANYSLA)
- Florida Acupuncture Association (FAA)
- American College of Acupuncture & Oriental Medicine (ACAOM)
- New York College of Traditional Chinese Medicine (NYCTCM)
- Atlantic Institute of Oriental Medicine (ATOM)
- Five Branches University (FBU)
The forum benefited from the generous sponsorship of Tianjiang Pharmaceutical, industry in the standardization, modernization, and internationalization of traditional Chinese medicine. This forum was intended as a bridge between Chinese medicine specialists and specialists at home and abroad. Stay tuned for the next one -- with English translation!